The success of immunization programs relies heavily on immunization program managers, who facilitate every aspect of immunization programs, from cost-effective procurement of vaccines to the vigilant monitoring of vaccine safety and efficacy. Sabin’s IAIM Network is the largest international network of immunization managers, offering opportunities to connect, share knowledge and strengthen skills required to effectively implement immunization programs.

Sabin Rising Star

The Sabin Rising Star Award honors an early-career professional who has demonstrated a commitment to the field of immunization and who exemplifies the Sabin Vaccine Institute’s mission to make vaccines more accessible, enable innovation and expand immunization across the globe. We seek nominations that reflect the diversity of global health work, unrestricted by gender, location or field of work.

The 2020 Rising Star Award will be presented on March 25, 2020, in Washington, D.C.

Submit a nomination

The success of immunization programs relies heavily on immunization program managers, who facilitate every aspect of immunization programs, from cost-effective procurement of vaccines to the vigilant monitoring of vaccine safety and efficacy. Sabin’s IAIM Network is the largest international network of immunization managers, offering opportunities to connect, share knowledge and strengthen skills required to effectively implement immunization programs.

Sabin Vaccine Institute Elects New Trustees Bringing Expertise to Support Program Growth

WASHINGTON, D.C. – The Sabin Vaccine Institute (Sabin) announces the appointment of three new members to its Board of Trustees. Joining the Board are Drs. Elizabeth Fox, Saad Omer and Jacqueline Shea, well-respected leaders whose range of skills and experience promise to advance Sabin’s aim to ensure all people, everywhere get the vaccines they need.

Accelerating the Development of a Universal Influenza Vaccine: A Report from the Sabin-Aspen Vaccine Science and Policy Group

The Sabin-Aspen Vaccine Science & Policy Group convened in 2018 to explore challenges and opportunities to develop a universal influenza vaccine. The group’s recommendations on how to overcome the scientific, financial and organizational barriers to developing a vaccine are synthesized in the report Accelerating the Development of a Universal Influenza Vaccine.

Sabin Vaccine Institute and The Aspen Institute Release Report Calling for Bold, New, and Coordinated Commitments to Making Universal Influenza Vaccines a Reality

WASHINGTON, D.C. – A new report released today by the Sabin-Aspen Vaccine Science & Policy Group, a joint initiative of the Sabin Vaccine Institute and the Aspen Institute, calls for an urgent, coordinated effort to amplify and focus resources on the long-sought, but overdue achievement of a universal influenza vaccine (UIV).
The success of immunization programs relies heavily on immunization program managers, who facilitate every aspect of immunization programs, from cost-effective procurement of vaccines to the vigilant monitoring of vaccine safety and efficacy. Sabin’s IAIM Network is the largest international network of immunization managers, offering opportunities to connect, share knowledge and strengthen skills required to effectively implement immunization programs.

Pages

Subscribe to RSS - Knowledge & Innovation